FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965490734> ?p ?o ?g. }

• W1965490734 endingPage "18266" @default.
• W1965490734 startingPage "18261" @default.
• W1965490734 abstract "Staurosporine, a protein kinase inhibitor, is known to mimic the effect of nerve growth factor (NGF) in promoting neurite outgrowth. To elucidate the mechanism by which staurosporine induces neurite outgrowth in PC-12 cells, we performed an in-gel kinase assay using myelin basic protein as a substrate, and found that staurosporine induced the activation of a kinase with an apparent molecular mass of 57 kDa. The dose of staurosporine required to activate this kinase was consistent with that required to induce neurite outgrowth. Interestingly, the staurosporine-activated kinase was immunoprecipitated by anti-c-Jun NH2-terminal kinase (JNK) isoforms antibody, but not by anti-JNK1-specific antibody or anti-ERK1 antibody, raising the possibility that this kinase is a novel JNK isoform. The substrate specificity of the kinase was distinct from those of osmotic shock-activated JNKs and NGF-activated ERK1. The kinase phosphorylates transcription factors including c-Jun, Elk-1, and ATF2, as well as myelin basic protein, suggesting that it plays a role in gene induction. Furthermore, staurosporine induced immediate-early genes including Nur77 and fos, but notjun. The activation of the staurosporine-activated kinase, as well as the induction of neurite outgrowth, did not require Ras function, while Ras was required for the activation of ERKs and neurite outgrowth induced by NGF. Taken together, these results indicate staurosporine specifically activates a JNK isoform, which may contribute to biological activities including neurite outgrowth. Staurosporine, a protein kinase inhibitor, is known to mimic the effect of nerve growth factor (NGF) in promoting neurite outgrowth. To elucidate the mechanism by which staurosporine induces neurite outgrowth in PC-12 cells, we performed an in-gel kinase assay using myelin basic protein as a substrate, and found that staurosporine induced the activation of a kinase with an apparent molecular mass of 57 kDa. The dose of staurosporine required to activate this kinase was consistent with that required to induce neurite outgrowth. Interestingly, the staurosporine-activated kinase was immunoprecipitated by anti-c-Jun NH2-terminal kinase (JNK) isoforms antibody, but not by anti-JNK1-specific antibody or anti-ERK1 antibody, raising the possibility that this kinase is a novel JNK isoform. The substrate specificity of the kinase was distinct from those of osmotic shock-activated JNKs and NGF-activated ERK1. The kinase phosphorylates transcription factors including c-Jun, Elk-1, and ATF2, as well as myelin basic protein, suggesting that it plays a role in gene induction. Furthermore, staurosporine induced immediate-early genes including Nur77 and fos, but notjun. The activation of the staurosporine-activated kinase, as well as the induction of neurite outgrowth, did not require Ras function, while Ras was required for the activation of ERKs and neurite outgrowth induced by NGF. Taken together, these results indicate staurosporine specifically activates a JNK isoform, which may contribute to biological activities including neurite outgrowth. Neurotrophic factors play a key role in the normal development of the nervous system by regulating both differentiation and apoptosis of neurons (1Levi M.R. Science. 1987; 237: 1154-1162Crossref PubMed Scopus (2681) Google Scholar). Nerve growth factor (NGF) 1The abbreviations used are: NGF, nerve growth factor; JNK, c-Jun NH2-terminal kinase; MBP, myelin basic protein; MEK, MAP kinase/ERK kinase; ERK, extracellular signal-regulated protein kinase; MAP, mitogen-activated protein; GST, glutathione S-transferase; kb, kilobase pair(s). 1The abbreviations used are: NGF, nerve growth factor; JNK, c-Jun NH2-terminal kinase; MBP, myelin basic protein; MEK, MAP kinase/ERK kinase; ERK, extracellular signal-regulated protein kinase; MAP, mitogen-activated protein; GST, glutathione S-transferase; kb, kilobase pair(s). is the prototype of this family of neurotrophins and its intracellular signaling pathways have been intensely studied using rat pheochromocytoma PC-12 cells, which undergo neuronal differentiation in response to NGF stimulation (1Levi M.R. Science. 1987; 237: 1154-1162Crossref PubMed Scopus (2681) Google Scholar, 2Greene L.A. Tischler A.S. Proc. Natl. Acad. Sci. U. S. A. 1976; 73: 2424-2428Crossref PubMed Scopus (4839) Google Scholar). NGF binds and activates its receptor, Trk, which leads to the activation of a guanine nucleotide-binding protein, Ras (3Kaplan D.R. Martin Z.D. Parada L.F. Nature. 1991; 350: 158-160Crossref PubMed Scopus (839) Google Scholar, 4Klein R. Jing S. Nanduri V. O'Rourke E. Barbacid M. Cell. 1991; 65: 189-197Abstract Full Text PDF PubMed Scopus (1144) Google Scholar, 5Nakafuku M. Satoh T. Kaziro Y. J. Biol. Chem. 1992; 267: 19448-19454Abstract Full Text PDF PubMed Google Scholar). Expression of oncogenic Ras in PC-12 cells induces neuronal differentiation (6Bar-Sagi D. Feramisco J.R. Cell. 1985; 42: 841-848Abstract Full Text PDF PubMed Scopus (568) Google Scholar), while introduction of anti-Ras antibody or dominant inhibitory Ras mutant into PC-12 cells blocks NGF-induced differentiation (7Hagag N. Halegoua S. Viola M. Nature. 1986; 319: 680-682Crossref PubMed Scopus (302) Google Scholar, 8Szeberenyi J. Cai H. Cooper G.M. Mol. Cell. Biol. 1990; 10: 5324-5332Crossref PubMed Scopus (276) Google Scholar), suggesting that Ras is necessary and sufficient for neuronal differentiation in PC-12 cells. The formation of GTP-Ras is followed first by the activation of Raf and then by activation of MEK (9Avruch J. Zhang X.F. Kyriakis J.M. Trends Biochem. Sci. 1994; 19: 279-283Abstract Full Text PDF PubMed Scopus (541) Google Scholar, 10Kyriakis J.M. App H. Zhang X.F. Banerjee P. Brautigan D.L. Rapp U.R. Avruch J. Nature. 1992; 358: 417-421Crossref PubMed Scopus (974) Google Scholar). MEK in turn activates the ERK family of MAP kinases, which then phosphorylate a variety of proteins including Elk-1 transcription factor (11Crews C.M. Erikson R.L. Cell. 1993; 74: 215-217Abstract Full Text PDF PubMed Scopus (296) Google Scholar, 12Gille H. Sharrocks A.D. Shaw P.E. Nature. 1992; 358: 414-417Crossref PubMed Scopus (814) Google Scholar, 13Marais R. Wynne J. Treisman R. Cell. 1993; 73: 381-393Abstract Full Text PDF PubMed Scopus (1104) Google Scholar). The expression of a dominant inhibitory mutant of Ras inhibits activation of the Raf/MEK/ERK kinase cascade (14Thomas S.M. DeMarco M. D'Arcangelo G. Halegoua S. Brugge J.S. Cell. 1992; 68: 1031-1040Abstract Full Text PDF PubMed Scopus (503) Google Scholar, 15Wood K. Sarnecki C. Roberts T.M. Blenis J. Cell. 1992; 68: 1041-1050Abstract Full Text PDF PubMed Scopus (661) Google Scholar, 16Troppmair J. Bruder J.T. App H. Cai H. Liptak L. Szeberenyi J. Cooper G.M. Rapp U.R. Oncogene. 1992; 7: 1867-1873PubMed Google Scholar). Furthermore, recent studies revealed that MEK and ERK play an important role in NGF-induced differentiation (17Cowley S. Paterson H. Kemp P. Marshall C.J. Cell. 1994; 77: 841-852Abstract Full Text PDF PubMed Scopus (1850) Google Scholar, 18Fukuda M. Gotoh Y. Tachibana T. Dell K. Hattori S. Yoneda Y. Nishida E. Oncogene. 1995; 11: 239-244PubMed Google Scholar). These results indicate the Ras/Raf/MEK/ERK signaling pathway plays a key role in NGF-induced differentiation in PC-12 cells. The molecular cloning of c-Jun NH2-terminal kinases (JNKs), also termed stress-activated protein kinases, led to the identification of JNKs as a member of the MAP kinase family of protein kinases (19Derijard B. Hibi M. Wu I.H. Barrett T. Su B. Deng T. Karin M. Davis R.J. Cell. 1994; 76: 1025-1037Abstract Full Text PDF PubMed Scopus (2953) Google Scholar, 20Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 21Sluss H.K. Barrett T. Derijard B. Davis R.J. Mol. Cell. Biol. 1994; 14: 8376-8384Crossref PubMed Scopus (444) Google Scholar). JNKs are activated by inflammatory cytokines and cellular stresses including ultraviolet irradiation, osmotic shock, and treatment with protein synthesis inhibitors, while ERKs are activated by growth factor stimulation (22Su B. Jacinto E. Hibi M. Kallunki T. Karin M. Ben N.Y. Cell. 1994; 77: 727-736Abstract Full Text PDF PubMed Scopus (849) Google Scholar, 23Hibi M. Lin A. Smeal T. Minden A. Karin M. Genes Dev. 1993; 7: 2135-2148Crossref PubMed Scopus (1708) Google Scholar, 24Galcheva G.Z. Derijard B. Wu I.H. Davis R.J. Science. 1994; 265: 806-808Crossref PubMed Scopus (530) Google Scholar, 25Zinck R. Cahill M.A. Kracht M. Sachsenmaier C. Hipskind R.A. Nordheim A. Mol. Cell. Biol. 1995; 15: 4930-4938Crossref PubMed Scopus (236) Google Scholar). Activation of JNKs requires the phosphorylation of JNK on Thr and Tyr, which is mediated by a dual specificity protein kinase (19Derijard B. Hibi M. Wu I.H. Barrett T. Su B. Deng T. Karin M. Davis R.J. Cell. 1994; 76: 1025-1037Abstract Full Text PDF PubMed Scopus (2953) Google Scholar). One of the JNK activators, MKK4 is activated by phosphorylation by another protein kinase, MEKK1 (26Derijard B. Raingeaud J. Barrett T. Wu I.H. Han J. Ulevitch R.J. Davis R.J. Science. 1995; 267: 682-685Crossref PubMed Scopus (1407) Google Scholar, 27Minden A. Lin A. McMahon M. Lange C.C. Derijard B. Davis R.J. Johnson G.L. Karin M. Science. 1994; 266: 1719-1723Crossref PubMed Scopus (1011) Google Scholar). Although the mechanism of MEKK1 activation is not fully understood, it appears that the signaling pathway leading to the activation of JNKs is distinct from the Ras/Raf/MEK signaling pathway, which is responsible for the activation of ERKs. Recent studies identified 10 isoforms of JNKs (28Gupta S. Barrett T. Whitmarsh A.J. Cavanagh J. Sluss H.K. Derijard B. Davis R.J. EMBO J. 1996; 15: 2760-2770Crossref PubMed Scopus (1177) Google Scholar). These isoforms arise from the alternative processing of transcripts from three different genes: those for JNK1, JNK2, and JNK3. Although similar in amino acid sequences, these JNK isoforms have distinct in vitro biochemical properties, suggesting they are not functionally redundant. Consistent with this, it has been shown that JNK1, but not JNK2, complements a defect in the expression of the MAP kinase, HOG1 in the yeast Saccharomyces cerevisiae (21Sluss H.K. Barrett T. Derijard B. Davis R.J. Mol. Cell. Biol. 1994; 14: 8376-8384Crossref PubMed Scopus (444) Google Scholar). A number of chemical compounds have been reported to induce neurite outgrowth. In this study, we investigated staurosporine-induced neurite outgrowth, and found staurosporine activated a protein kinase with an apparent molecular mass of 57 kDa. Interestingly, the staurosporine-activated kinase was recognized by anti-JNK isoforms antibody, but not by anti-JNK1-specific or anti-ERK1-specific antibody, suggesting this kinase is a JNK. However, the apparent molecular mass of this kinase was different from those of osmotic shock-activated JNKs whose molecular masses were 46 and 55 kDa. Interestingly, staurosporine did not activate osmotic shock-activated kinases, and conversely, osmotic shock did not induce the staurosporine-activated kinase activation. Furthermore, the substrate specificity of the staurosporine-activated kinase was different from that of JNK1 and ERK1. Taken together these results indicate that staurosporine specifically activates a JNK-related kinase, which is different from well characterized stress-activated JNKs. The staurosporine-activated kinase has a distinct substrate specificity, raising the possibility that it is involved in distinct biological activity including differentiation. PC-12 cells were maintained in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum and 5% calf serum. PC-12 cells expressing RasN17 (M-M17-26 cells, provided by Geoffrey M. Cooper (Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA) (8Szeberenyi J. Cai H. Cooper G.M. Mol. Cell. Biol. 1990; 10: 5324-5332Crossref PubMed Scopus (276) Google Scholar) were maintained in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum, 5% calf serum, and 400 μg/ml G418. The GST-c-Jun, GST-Elk-1, and GST-ATF2 expression plasmids were provided by Roger J. Davis (University of Massachusetts, Worcester). These plasmids were expressed in a bacteria strain, BL21(DE3), and GST fusion proteins were purified by glutathione chromatography as described (29Smith D.B. Johnson K.S. Gene ( Amst. ). 1988; 67: 31-40Crossref PubMed Scopus (5043) Google Scholar). In-gel kinase assay was performed essentially as described previously (30Gotoh Y. Nishida E. Yamashita T. Hoshi M. Kawakami M. Sakai H. Eur. J. Biochem. 1990; 193 (2nd Ed.): 661-669Crossref PubMed Scopus (321) Google Scholar). Subconfluent dishes of PC-12 cells or PC-12 cells expressing RasN17 were lysed in MAP kinase extraction buffer, and the protein concentration was determined by Bio-Rad protein assay. To assay total cell lysate, equal amounts of protein (50–100 μg) were electrophoresed in 10% SDS-polyacrylamide gels containing either myelin basic protein (MBP) (0.5 mg/ml), GST-c-Jun (1–79) (0.1 mg/ml), GST-ATF2 (0.1 mg/ml), or GST-Elk-1 (0.1 mg/ml) as a substrate. For immunoprecipitation, the NaCl concentration of the cell extract was adjusted to 150 mm, 2 μg of each antibody was added to 100 μl of cell extract containing 500 μg of protein, and incubation carried out for 1 h at 4 °C. Anti-JNK isoforms antibody and anti-ERK1 antibody were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-JNK1-specific antibody was purchased from PharMingen (San Diego, CA). Next, 50 μl of 10% protein A-Sepharose was added and the mixture incubated for 1 h at 4 °C. Protein A-Sepharose beads were collected by centrifugation and washed four times with MAP kinase extraction buffer. SDS-polyacrylamide gel electrophoresis sample buffer was added to protein A-Sepharose beads and samples were electrophoresed in SDS-polyacrylamide gels containing various substrates as indicated. Following electrophoresis, SDS were removed from the gel, protein was renatured, and a kinase assay was carried out by incubating the gel in buffer containing [γ-32P]ATP. Gels were washed, and incorporated radioactivity was quantified using an image analyzer (BAS2000, Fuji Film Co. Ltd., Japan). Total cytoplasmic RNA was isolated as described (31Sambrook J. Fritsch E.F. Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY1989Google Scholar). RNAs (15 μg) were electrophoresed in 1% formaldehyde-agarose gels and transferred to Biodyne-B membrane (East Hills, NY). Filters were prehybridized, hybridized and washed according to the manufacturer's instructions. The following DNA fragments were32P-labeled with a random priming kit (Life Technologies, Inc.) for use as probes: fos, a 1-kb PstI fragment from pfos-1 (32Curran T. Peters G. Van B.C. Teich N.M. Verma I.M. J. Virol. 1982; 44: 674-682Crossref PubMed Google Scholar); jun, a 0.9-kb PstI fragment of human jun (33Bohmann D. Bos T.J. Admon A. Nishimura T. Vogt P.K. Tjian R. Science. 1987; 238: 1386-1392Crossref PubMed Scopus (953) Google Scholar); Nur77, a 1.9-kbEcoRI-KpnI fragment from a pGEM-Nur77 construct (34Hazel T.G. Nathans D. Lau L.F. Proc. Natl. Acad. Sci. U. S. A. 1988; 85: 8444-8448Crossref PubMed Scopus (400) Google Scholar). We studied differentiation in PC-12 cells induced by chemical compounds and found that staurosporine was a potent inducer of neurite outgrowth. As reported (35Hashimoto S. Hagino A. Exp. Cell. Res. 1989; 184: 351-359Crossref PubMed Scopus (38) Google Scholar, 36Tischler A.S. Ruzicka L.A. Perlman R.L. J. Neurochem. 1990; 55: 1159-1165Crossref PubMed Scopus (60) Google Scholar), staurosporine induced neurite outgrowth at concentrations of as low as 4–20 ng/ml, with maximal induction obtained at 100 ng/ml (Fig. 1). Staurosporine induced neurite outgrowth faster than NGF. After 6 h of staurosporine treatment, small neurites were observed. Maximal neurite outgrowth was obtained after 24 h of treatment, and was comparable to that obtained by 3 days of treatment with NGF. We also tested K-252a, a staurosporine-related compound that exhibits similar effects on a variety of kinases, and found that K-252a did not induce neurite outgrowth at a similar range of concentration (date not shown). Since ERK1 and ERK2 of the MAP kinase family have been shown to play an important role in NGF-induced differentiation (18Fukuda M. Gotoh Y. Tachibana T. Dell K. Hattori S. Yoneda Y. Nishida E. Oncogene. 1995; 11: 239-244PubMed Google Scholar), we tested whether staurosporine can induce MAP kinases. To this end, we conducted an in-gel kinase assay using MBP as a substrate (Fig.2). Consistent with previous reports (30Gotoh Y. Nishida E. Yamashita T. Hoshi M. Kawakami M. Sakai H. Eur. J. Biochem. 1990; 193 (2nd Ed.): 661-669Crossref PubMed Scopus (321) Google Scholar), NGF strongly induced ERK1 and ERK2 at 5 min after stimulation and the activity decreased with time. Interestingly, staurosporine induced a kinase with an apparent molecular mass of 57 kDa (Fig. 2 A). When MBP was omitted from the gel, this band was not detected, indicating the phosphorylation was not due to autophosphorylation (data not shown). In contrast to the rapid and transient NGF-induced activation of ERKs, staurosporine induced a prolonged activation of the 57-kDa kinase (Fig.2 B). Weak activation was observed at 5 min after stimulation, and maximal activation was obtained at 120 min after stimulation. Weak activation of the kinase was induced with staurosporine treatment as low as 4 ng/ml, while maximal activation was obtained at a concentration of 100 ng/ml (Fig. 2 C). Differences in molecular mass indicate that the staurosporine activated kinase is distinct from ERK1 and ERK2, both of which are thought to be involved in NGF-induced differentiation. However, the concentration of staurosporine required for the activation of the 57-kDa kinase was similar to that required for the induction of neurite outgrowth, raising the possibility that the 57-kDa kinase plays a role in staurosporine-induced neurite outgrowth. Consistent with this, K-252a, a compound similar to staurosporine in its structure and biological activities in inhibiting kinases, did not induce neurite outgrowth and did not induce the activation of the 57-kDa kinase (date not shown). The MAP kinase family is part of a large family of serine-threonine protein kinases (19Derijard B. Hibi M. Wu I.H. Barrett T. Su B. Deng T. Karin M. Davis R.J. Cell. 1994; 76: 1025-1037Abstract Full Text PDF PubMed Scopus (2953) Google Scholar, 20Kyriakis J.M. Banerjee P. Nikolakaki E. Dai T. Rubie E.A. Ahmad M.F. Avruch J. Woodgett J.R. Nature. 1994; 369: 156-160Crossref PubMed Scopus (2411) Google Scholar, 21Sluss H.K. Barrett T. Derijard B. Davis R.J. Mol. Cell. Biol. 1994; 14: 8376-8384Crossref PubMed Scopus (444) Google Scholar). Since JNKs are a subfamily of the MAP kinase family, we tested whether the staurosporine-activated kinase belongs to the JNK subfamily. To this end, we used three antibodies. 1) Anti-JNK isoforms antibody was raised against a full length recombinant protein of JNK2, and recognizes JNK1 and JNK2. 2) Anti-JNK1-specific antibody recognizes only JNK1. 3) Anti-ERK1 antibody recognizes ERK1 specifically. Using these antibodies, we immunoprecipitated JNKs and ERK1 from cells treated with either NGF, staurosporine or osmotic shock and tested for their kinase activities using an in-gel kinase assay (Fig. 3). As expected, NGF induced kinases with molecular masses of 42 and 44 kDa, and the 44-kDa kinase was recognized by anti-ERK1 antibody, but not by anti-JNK isoforms antibody or anti-JNK1-specific antibody, indicating NGF specifically activates ERK1 and ERK2. Osmotic shock, induced by treatment of cells with 0.5 m sorbitol for 30 min, induced the activation of kinases with molecular masses of 46 and 55 kDa, which probably represent mixtures of JNK1 and JNK2 (28Gupta S. Barrett T. Whitmarsh A.J. Cavanagh J. Sluss H.K. Derijard B. Davis R.J. EMBO J. 1996; 15: 2760-2770Crossref PubMed Scopus (1177) Google Scholar). Consistent with this, these kinases were recognized by anti-JNK isoforms antibody and anti-JNK1-specific antibody, but not by anti-ERK1 antibody. Anti-JNK isoforms antibody only recognized the 55-kDa isoform of JNKs, which is probably due to the preferential recognition of the COOH-terminal region of JNKs by this antibody. The kinase activated by staurosporine was recognized by anti-JNK isoforms antibody, but not by anti-JNK1-specific antibody or anti-ERK1 antibody. Note that the staurosporine-activated kinase has a slower mobility in SDS-polyacrylamide gel compared with those activated by osmotic shock, indicating they are distinct kinases (Figs. 3 and 4). Furthermore, the 57-kDa kinase was the only kinase induced by staurosporine treatment.Figure 4The substrate specificity of the staurosporine-activated kinase. Cells were left untreated (−) or incubated with 100 ng/ml NGF for 5 min (NGF), 100 ng/ml staurosporine for 120 min (SSP), or 0.5 msorbitol for 30 min (SRB). Immunoprecipitation was performed as described under “Materials and Methods.” The kinase activity was determined by an in-gel kinase assay using as a substrate the protein indicated. The positions of staurosporine-activated kinase, JNK1, and ERK1 are indicated by arrows.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Although the staurosporine-activated kinase was recognized by anti-JNK isoforms antibody, it is possible that the signal detected by an in-gel kinase assay represented multiple kinase activities. To test this possibility, we analyzed the staurosporine-treated cell extract by chromatography using a Mono Q column. Since only a single peak of 57-kDa kinase activity was identified (data not shown), it is therefore unlikely that the 57-kDa kinase activity detected by an in-gel kinase assay contains multiple kinase activities. Taken together, these results indicate that staurosporine specifically activates a kinase that is immunologically related to JNKs, but is distinct from JNK1 and JNK2. It has been reported that ERKs and JNKs have a different substrate specificity, which is thought to contribute to their distinct biological activities. We therefore determined the substrate specificity of the staurosporine-activated kinase (Fig. 4). As expected, ERK1 that was activated by NGF efficiently phosphorylated MBP and Elk-1. In contrast, JNK1 activated by osmotic shock strongly phosphorylated ATF2, and, to a lesser extent, Elk-1 and c-Jun. However, the staurosporine-activated kinase phosphorylated MBP, Elk-1, ATF2, and c-Jun. These results indicate that, although the staurosporine-activated kinase is related to JNKs, it has a different substrate specificity to JNK1 and ERK1. Both ERKs and JNKs are believed to regulate gene expression by phosphorylating transcription factors (37Davis R.J. Mol. Reprod. Dev. 1995; 42: 459-467Crossref PubMed Scopus (383) Google Scholar). Similarly, the staurosporine-activated kinase was able to phosphorylate several transcription factors. However, since the staurosporine-activated kinase had a distinct substrate specificity, we tested whether staurosporine can induce transcription of early response genes including Nur77, fos, and jun (Fig.5). Interestingly, staurosporine inducedNur77 and fos transcription. Quantitation of the induction indicated that the induction of Nur77 by staurosporine was 2.9-fold at 3 h after stimulation, while that by NGF was 12.8-fold at 45 min after stimulation. Similarly, staurosporine induced fos transcription by 1.9-fold after 2 h of stimulation, while NGF induced fos transcription by 8.0-fold after 45 min of stimulation. Although the induction of Nur77and fos by staurosporine was smaller than that of NGF, the induction of these genes by staurosporine is significant, becausejun was not induced by staurosporine. It is worthy to note that staurosporine induced prolonged transcriptional activation with a maximal activation at 180 min after treatment, while NGF-induced transcriptional activation was more rapid and transient. Thus it appears staurosporine induces transcriptional activation of early response genes, but the induction was different from that by NGF with respect to spices of genes and time course of the induction. It has been shown that the signaling pathways leading to the activation of ERKs and JNKs are distinct (27Minden A. Lin A. McMahon M. Lange C.C. Derijard B. Davis R.J. Johnson G.L. Karin M. Science. 1994; 266: 1719-1723Crossref PubMed Scopus (1011) Google Scholar). Since Ras function is necessary for the NGF-induced activation of ERKs as well as the NGF-induced neurite outgrowth, we investigated whether Ras is required for activation of the 57-kDa kinase and neurite outgrowth in PC-12 cells induced by staurosporine (Fig. 6). As previously reported (14Thomas S.M. DeMarco M. D'Arcangelo G. Halegoua S. Brugge J.S. Cell. 1992; 68: 1031-1040Abstract Full Text PDF PubMed Scopus (503) Google Scholar, 15Wood K. Sarnecki C. Roberts T.M. Blenis J. Cell. 1992; 68: 1041-1050Abstract Full Text PDF PubMed Scopus (661) Google Scholar), NGF did not induce activation of ERKs in dominant inhibitory mutant Ras (RasN17)-expressing PC-12 cells. In contrast, staurosporine did activate the 57-kDa kinase in RasN17-expressing PC-12 cells to an extent similar to that in wild type PC-12 cells. Similarly, Ras function was not required for the activation of JNKs induced by osmotic shock. Similar results were obtained in neurite outgrowth in PC-12 cells (Fig.7). RasN17 interfered with NGF-induced neurite outgrowth, but not staurosporine-induced neurite outgrowth. These results suggest that staurosporine and NGF induce neurite outgrowth via distinct signaling pathways. ERK1 and ERK2 of the MAP kinase family play a key role in NGF-induced neuronal differentiation in PC-12 cells. Since staurosporine is a potent inhibitor of protein kinases and also an inducer of neurite outgrowth in PC-12 cells, in this study, we first investigated whether staurosporine activates the signaling pathway that leads to the activation of members of the MAP kinase family. Interestingly, we found that staurosporine activated a kinase detected by an in-gel kinase assay using MBP as a substrate. This kinase differed from known ERKs in molecular mass, and in that it was not recognized by anti-ERK1-specific antibody. However, it was recognized by anti-JNK isoforms antibody, which recognizes JNK1, JNK2, and probably other isoforms of JNKs. Therefore it is most likely that this staurosporine-activated kinase is a JNK. The finding that staurosporine activates a member of the JNK family is consistent with a previous report (38Xia Z. Dickens M. Raingeaud J. Davis R.J. Greenberg M.E. Science. 1995; 270: 1326-1331Crossref PubMed Scopus (5028) Google Scholar). However, the molecular mass of the kinase is 57 kDa, which is distinct from those of well characterized JNKs activated by various stimuli including osmotic shock (Figs. 3 and 4). Furthermore, the substrate specificity of the kinase was also distinct (Fig. 4). Recent detailed analysis led to the identification of 10 different JNK isoforms that arise from the alternative processing of transcripts from three different genes (28Gupta S. Barrett T. Whitmarsh A.J. Cavanagh J. Sluss H.K. Derijard B. Davis R.J. EMBO J. 1996; 15: 2760-2770Crossref PubMed Scopus (1177) Google Scholar). It turned out that the JNKs with the molecular mass of 46 and 55 kDa represented a mixture of JNK isoforms. Thus it is possible that the staurosporine-activated kinase is a novel JNK isoform. Consistent with this, anti-JNK1-specific antibody did not recognize the staurosporine-activated kinase. However, we cannot exclude the possibility that this kinase is identical to JNK3-α2, which has a molecular mass of 57 kDa (28Gupta S. Barrett T. Whitmarsh A.J. Cavanagh J. Sluss H.K. Derijard B. Davis R.J. EMBO J. 1996; 15: 2760-2770Crossref PubMed Scopus (1177) Google Scholar). If this is the case, our paper is the first to describe the activation and the distinct substrate specificity of JNK3-α2. Since staurosporine inhibits a variety of kinases including the ERKs of the MAP kinase family, it is unlikely that staurosporine activates the 57-kDa kinase by a direct interaction. Members of the MAP kinase family of protein kinases are known to be activated by several signaling pathways. It is interesting to note that staurosporine did not activate JNKs having molecular masses of 46 and 55 kDa. Conversely, osmotic shock failed to activate the 57-kDa kinase. It thus appeared that the signaling pathway leading to the activation of the 57-kDa kinase is specifically activated by staurosporine. It has been shown that JNKs become active only when a Thr and a Tyr residue in a Thr-Pro-Tyr motif are phosphorylated (19Derijard B. Hibi M. Wu I.H. Barrett T. Su B. Deng T. Karin M. Davis R.J. Cell. 1994; 76: 1025-1037Abstract Full Text PDF PubMed Scopus (2953) Google Scholar). Although a kinase, MKK4, was identified as being responsible for this phosphorylation (26Derijard B. Raingeaud J. Barrett T. Wu I.H. Han J. Ulevitch R.J. Davis R.J. Science. 1995; 267: 682-685Crossref PubMed Scopus (1407) Google Scholar), the involvement of several other JNK kinases has also been suggested (39Moriguchi T. Kawasaki H. Matsuda S. Gotoh Y. Nishida E. J. Biol. Chem. 1995; 270: 12969-12972Abstract Full Text Full Text PDF PubMed Scopus (123) Google Scholar, 40Meier R. Rouse J. Cuenda A. Nebreda A.R. Cohen P. Eur. J. Biochem. 1996; 236: 796-805Crossref PubMed Scopus (112) Google Scholar). It is established that ERKs and JNKs are activated by distinct signaling pathways as defined by MAP kinase kinases (also termed MKKs or SAPKs) (41Zhou G. Bao Z.Q. Dixon J.E. J. Biol. Chem. 1995; 270: 12665-12669Abstract Full Text Full Text PDF PubMed Scopus (536) Google Scholar, 42English J.M. Vanderbilt C.A. Xu S. Marcus S. Cobb M.H. J. Biol. Chem. 1995; 270: 28897-28902Abstract Full Text Full Text PDF PubMed Scopus (184) Google Scholar, 43Moriguchi T. Kuroyanagi N. Yamaguchi K. Gotoh Y. Irie K. Kano T. Shirakabe K. Muro Y. Shibuya H. Matsumoto K. Nishida E. Hagiwara M. J. Biol. Chem. 1996; 271: 13675-13679Abstract Full Text Full Text PDF PubMed Scopus (406) Google Scholar). However, to our knowledge, no specific signaling pathway that distinguishes JNK isoforms has been reported. Staurosporine specifically activates the 57-kDa kinase. Thus, we conclude by suggesting that staurosporine activates a specific kinase cascade which leads to the activation of the 57-kDa kinase, but not other isoforms of JNKs. Staurosporine was originally considered to be a specific inhibitor of protein kinase C, but further studies revealed it also inhibits a variety of tyrosine kinases as well as serine-threonine kinases. At this point, it is not clear whether the inhibition of kinase(s) contributes to the activation of the 57-kDa kinase. However, a structurally related compound, K-252a, which also inhibits protein kinases, did not activate the 57-kDa kinase (data not shown). Similarly, K-252a did not induce neurite outgrowth in PC-12 cells (data not shown; Ref. 35Hashimoto S. Hagino A. Exp. Cell. Res. 1989; 184: 351-359Crossref PubMed Scopus (38) Google Scholar). These results suggest the action of staurosporine to induce the 57-kDa kinase activation and neurite outgrowth is not due to the inhibition of kinases. Staurosporine did not activate ERK1 and ERK2 of MAP kinases, which play an important role in NGF-induced differentiation. However, the 57-kDa kinase activated by staurosporine phosphorylated MBP and ERK1, which suggests the 57-kDa kinase can phosphorylate and activate common downstream target(s) to ERKs. Furthermore, the concentrations required for the activation of the 57-kDa kinase and for the induction of neurite outgrowth are almost the same, which suggest the involvement of the 57-kDa kinase in the induction of neurite outgrowth. This conclusion is supported by experiments using a compound, K-252a, which is structurally similar to staurosporine and also has similar inhibition profile on a variety of kinases. Despite these similarities, K-252a did not induce neurite outgrowth, and importantly, failed to activate the 57-kDa kinase. The MAP kinases are part of a large family of serine-threonine protein kinases. However, their physiological roles are thought to be distinct. For example, ERKs are thought to play a key role in the differentiation of PC-12 cells, while JNKs may play a role in induction of apoptosis (18Fukuda M. Gotoh Y. Tachibana T. Dell K. Hattori S. Yoneda Y. Nishida E. Oncogene. 1995; 11: 239-244PubMed Google Scholar, 38Xia Z. Dickens M. Raingeaud J. Davis R.J. Greenberg M.E. Science. 1995; 270: 1326-1331Crossref PubMed Scopus (5028) Google Scholar). Consistent with this, the substrate specificities of these kinases are different. MBP is effectively phosphorylated by ERK1, while ATF2 was strongly phosphorylated by JNK1. Interestingly, the staurosporine-activated 57-kDa kinase phosphorylated both MBP and ATF2 as well as Elk-1 and c-Jun, suggesting the staurosporine-activated kinase may have similar but distinct biological roles. Consistent with this, staurosporine induced transcriptional activation of Nur77 and fos, but not jun. Furthermore, although staurosporine induces neurite outgrowth in PC-12 cells, it also has been reported that apoptosis was induced by staurosporine under certain conditions (38Xia Z. Dickens M. Raingeaud J. Davis R.J. Greenberg M.E. Science. 1995; 270: 1326-1331Crossref PubMed Scopus (5028) Google Scholar). InDrosophila, recent studies revealed that a JNK homolog mediates cell morphogenesis and an immune response (44Sluss H.K. Han Z. Barrett T. Davis R.J. Ip Y.T. Genes Dev. 1996; 10: 2745-2758Crossref PubMed Scopus (338) Google Scholar, 45Riesgo-Escovar J.R. Jenni M. Fritz A. Hafen E. Genes Dev. 1996; 10: 2759-2768Crossref PubMed Scopus (282) Google Scholar). Further studies will be necessary to identify the biological significance of the staurosporine-activated kinase. We are grateful to R. Davis for providing plasmids encoding GST-c-Jun, GST-ATF2, and GST-Elk-1. We also thank T. Endo, T. Sudo, and T. Usui for their helpful suggestions." @default.
• W1965490734 created "2016-06-24" @default.
• W1965490734 creator A5037891082 @default.
• W1965490734 creator A5054922975 @default.
• W1965490734 creator A5055689145 @default.
• W1965490734 date "1997-07-01" @default.
• W1965490734 modified "2023-09-30" @default.
• W1965490734 title "Specific Activation of a c-Jun NH2-terminal Kinase Isoform and Induction of Neurite Outgrowth in PC-12 Cells by Staurosporine" @default.
• W1965490734 cites W1572174728 @default.
• W1965490734 cites W1572954385 @default.
• W1965490734 cites W1778251976 @default.
• W1965490734 cites W1968199586 @default.
• W1965490734 cites W1970587959 @default.
• W1965490734 cites W1971977518 @default.
• W1965490734 cites W1976385326 @default.
• W1965490734 cites W1977052613 @default.
• W1965490734 cites W1978798502 @default.
• W1965490734 cites W1981705099 @default.
• W1965490734 cites W1984903682 @default.
• W1965490734 cites W1985021605 @default.
• W1965490734 cites W1985417906 @default.
• W1965490734 cites W1989480480 @default.
• W1965490734 cites W1998084304 @default.
• W1965490734 cites W1998487776 @default.
• W1965490734 cites W1999157780 @default.
• W1965490734 cites W2000082154 @default.
• W1965490734 cites W2000371106 @default.
• W1965490734 cites W2005900169 @default.
• W1965490734 cites W2010488494 @default.
• W1965490734 cites W2021176672 @default.
• W1965490734 cites W2026951979 @default.
• W1965490734 cites W2030271387 @default.
• W1965490734 cites W2032984787 @default.
• W1965490734 cites W2037831105 @default.
• W1965490734 cites W2038087154 @default.
• W1965490734 cites W2057126981 @default.
• W1965490734 cites W2063695629 @default.
• W1965490734 cites W2068446924 @default.
• W1965490734 cites W2069132844 @default.
• W1965490734 cites W2072061824 @default.
• W1965490734 cites W2077880395 @default.
• W1965490734 cites W2083612840 @default.
• W1965490734 cites W2091309613 @default.
• W1965490734 cites W2092109378 @default.
• W1965490734 cites W2093652869 @default.
• W1965490734 cites W2115120555 @default.
• W1965490734 cites W2134468110 @default.
• W1965490734 cites W2155868854 @default.
• W1965490734 doi "https://doi.org/10.1074/jbc.272.29.18261" @default.
• W1965490734 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9218464" @default.
• W1965490734 hasPublicationYear "1997" @default.
• W1965490734 type Work @default.
• W1965490734 sameAs 1965490734 @default.
• W1965490734 citedByCount "94" @default.
• W1965490734 countsByYear W19654907342012 @default.
• W1965490734 countsByYear W19654907342014 @default.
• W1965490734 countsByYear W19654907342015 @default.
• W1965490734 countsByYear W19654907342016 @default.
• W1965490734 countsByYear W19654907342017 @default.
• W1965490734 countsByYear W19654907342018 @default.
• W1965490734 countsByYear W19654907342023 @default.
• W1965490734 crossrefType "journal-article" @default.
• W1965490734 hasAuthorship W1965490734A5037891082 @default.
• W1965490734 hasAuthorship W1965490734A5054922975 @default.
• W1965490734 hasAuthorship W1965490734A5055689145 @default.
• W1965490734 hasBestOaLocation W19654907341 @default.
• W1965490734 hasConcept C104317684 @default.
• W1965490734 hasConcept C113246987 @default.
• W1965490734 hasConcept C153911025 @default.
• W1965490734 hasConcept C184235292 @default.
• W1965490734 hasConcept C185592680 @default.
• W1965490734 hasConcept C195794163 @default.
• W1965490734 hasConcept C202751555 @default.
• W1965490734 hasConcept C2779084600 @default.
• W1965490734 hasConcept C2779087070 @default.
• W1965490734 hasConcept C2779664074 @default.
• W1965490734 hasConcept C41008148 @default.
• W1965490734 hasConcept C53345823 @default.
• W1965490734 hasConcept C55493867 @default.
• W1965490734 hasConcept C76155785 @default.
• W1965490734 hasConcept C86339819 @default.
• W1965490734 hasConcept C86803240 @default.
• W1965490734 hasConcept C95444343 @default.
• W1965490734 hasConceptScore W1965490734C104317684 @default.
• W1965490734 hasConceptScore W1965490734C113246987 @default.
• W1965490734 hasConceptScore W1965490734C153911025 @default.
• W1965490734 hasConceptScore W1965490734C184235292 @default.
• W1965490734 hasConceptScore W1965490734C185592680 @default.
• W1965490734 hasConceptScore W1965490734C195794163 @default.
• W1965490734 hasConceptScore W1965490734C202751555 @default.
• W1965490734 hasConceptScore W1965490734C2779084600 @default.
• W1965490734 hasConceptScore W1965490734C2779087070 @default.
• W1965490734 hasConceptScore W1965490734C2779664074 @default.
• W1965490734 hasConceptScore W1965490734C41008148 @default.
• W1965490734 hasConceptScore W1965490734C53345823 @default.
• W1965490734 hasConceptScore W1965490734C55493867 @default.
• W1965490734 hasConceptScore W1965490734C76155785 @default.
• W1965490734 hasConceptScore W1965490734C86339819 @default.

• next